Clinical Trial Update: Serplulimab Combined With CCRT for LS-SCLC. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating serplulimab in combination with concurrent chemoradiotherapy for limited-stage small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING